APLN and pulmonary arterial hypertension: Mutations in the bone morphogenic protein receptor type 2 (BMPR2) gene and alterations in BMPR2 signalling can predispose to pulmonary vascular remodelling and the development of pulmonary arterial hypertension.129 This may be partly due to regulation of the apelin system.